PHLCX Mutual Fund

NAV$9.31

Fund Essentials - as of Nov 28, 2025

Net Assets
$11M
Expense Ratio
1.97%
Dividend Yield (Current)
51.28%
Holdings
51
Inception Date
Jun 30, 1999
Fund Family
PGIM Investments
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+0.20%
1 Year+15.54%
3 Year+18.54%
5 Year+8.93%
10 Year+12.77%

Asset Allocation

Stocks: 93.29%
Cash: 6.70%
Other: 0.01%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co16.48%
TMOThermo Fisher5.39%
-(Pipa070) Pgim Core Government Money Market Fund5.29%
DHRDanaher Corp5.01%
ARGX:ASArgenx Se Spon Adr Each Rep 1 Ord Shs4.62%
Top 10 Concentration: 51.22%Report Date: Nov 28, 2025
Download all 51 holdings for PHLCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
51.28%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

PHLCX Mutual Fund Overview

PHLCX Mutual Fund (PGIM Jennison Health Sciences Fund Class C) is managed by PGIM Investments with $10.7M in net assets. PHLCX expense ratio is 1.97%, holding 51 positions across sectors including Health Care, Unknown, Other. Inception date: 1999-06-30.

PHLCX performance shows a YTD return of 0.20%. The 1-year return is 15.54% and the 5-year return is 8.93%. PHLCX dividend yield stands at 51.28%, paid annually.

PHLCX top holdings include Eli Lilly & Co (16.5%), Thermo Fisher (5.4%), (Pipa070) Pgim Core Government Money Market Fund (5.3%), Danaher Corp (5.0%), Argenx Se Spon Adr Each Rep 1 Ord Shs (4.6%). View all PHLCX holdings, sector breakdown, or dividend history.

PHLCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PHLCX alternatives are available via the screener, along with tax-loss harvesting opportunities.